← back to database
SOSV provides early-stage funding and accelerator-style support for startups in human and planetary health. The firm operates program-driven models like HAX and IndieBio, offering facilities, engineering resources, lab equipment, and expert guidance to accelerate product development and subsequent fundraising. It targets deep tech across health and environmental sectors, often assisting portfolio companies through critical early rounds. By combining capital with hands-on development programs, SOSV helps startups scale to reach market traction and broader investment milestones.
Primary stage
Initial check size
Hardware / software
Investment focus
Investment style
Specialist
Data last enriched
Aug 14, 2026
Investing team
- Sean O'SullivanManaging General Partner
- Cyril EbersweilerGeneral Partner & Managing Director, HAX
- Pae WuGeneral Partner & CTO
- Po BronsonGeneral Partner & Managing Director, SOSV SF
- Stephen ChambersGeneral Partner & Managing Director, SOSV NY
- Mohan S. IyerGeneral Partner
- Avra van der ZeeGeneral Partner
- Deborah ZajacGeneral Partner
- Benjamin JoffeSenior Partner
- Westley DangPartner
- Andrew GollachPartner
- Alex KopelyanPartner & Senior Director
- Susan SchoferPartner & Chief Science Officer
- Sabriya StukesPartner & Chief Science Officer
- Parikshit SharmaPartner
- Ghaith AlghamdiPrincipal
- Alexander Hall-DanielsPrincipal
- Duncan TurnerGeneral Partner & Managing Director, SOSV HAX
- William Bao BeanVenture Partner
- Shawn BroderickVenture Partner
- Bill LiaoVenture Partner
- Oscar RamosVenture Partner